Chronic infection with Helicobacter pylori cagA-positive strains is the strongest risk factor for
gastric cancer. The cagA gene product, CagA, is delivered into gastric epithelial cells via the …

As Helicobacter pylori management has become more challenging and less efficient over
the last decade, the interest in innovative interventions is growing by the day. Probiotic co …

Helicobacter pylori (H. pylori) is one of the most common human pathogens, affecting half of
the world's population. Approximately 20% of the infected patients develop gastric ulcers or …

Helicobacter pylori causes persistent infection in the gastric epithelium of more than half of
the world's population, leading to the development of severe complications such as peptic …

Colonization of the human stomach with Helicobacter pylori strains containing the cag
pathogenicity island is a risk factor for development of gastric cancer. The cag pathogenicity …

The changes of gastric microbiome across stages of neoplastic progression remain poorly
understood, especially for intraepithelial neoplasia (IN) which has been recognized as a …

In the human body, each microbial habitat exhibits a different microbial population pattern,
and these distinctive microflorae are highly related to the development of diseases. The …

The original strategies developed by Helicobacter pylori to persistently colonise its host and
to deregulate its cellular functions make this bacterium an outstanding model to study host …

Abstract Objective Eradication of Helicobacter pylori (H. pylori) could not completely prevent
the progression of gastric cancer (GC), suggesting that non-H. pylori bacteria may …

While emerging evidence highlights the significance of gut microbiome in gastrointestinal
infectious diseases, treatments like Fecal Microbiota Transplantation (FMT) and probiotics …